Abbott Laboratories (ABT) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped ABT stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: Abbott Laboratories is well-positioned for substantial growth, driven by its strong fundamentals, innovative product lineup, and consistent earnings performance. While legal and regulatory challenges present risks, the company's proactive strategies in healthcare innovation and strong analyst backing build overarching bullish sentiment. The saved 1-year distribution is P10 $75, P50 $120, and P90 $140.
Last analyzed · Model: gpt-4o
Abbott Laboratories Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $75 | Pessimistic plausible scenario |
| P50 | $120 | Median scenario |
| P90 | $140 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
Abbott's consistent earnings beats and strong revenue growth projections position it favorably for a strong year ahead. However, legal challenges and minor clinical setbacks contribute to some downside risk.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this ABT analysis generated?
May 22, 2026.
Is this a guaranteed ABT prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full ABT stock analysis · ABT sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.